“…In all cases, a period of 1 week was allowed to elapse between randomization and this would allow time for each rat to adapt to new cage mates and re-establish relationships and hierarchy and thereby reduce stresses to the animals that could potentially have an impact on the study outcomes. The groups were designated: (1) Control (vehicle only), in which rats were to receive two subcutaneous (SC) injections of saline (ISO vehicle) in a volume of 10 ml and only normal saline per os daily (100 ml/dosing) in the 28-day ''post-MI induction'' period; (2) ISO only, in which rats were to be given ISO (250 mg/kg, SC; Sigma, St. Louis, MO) dissolved in saline once daily for 2 successive days to induce MI (dose was chosen based on Kannan and Quine 2013) and then only normal saline in the post-MI induction period; (3) BM-MNC group, in which rats were to be given an IV injection of 14 Â 10 6 newly-isolated BM-MNC in 10 ml PBS via the lateral tail vein on Day 1, 24 h after induction of MI by ISO and then normal saline per os daily in the 28-day ''post-MI induction'' period; (4) PRAV group, in which rats were to be given PRAV (20 mg/kg) per os daily in the 28-day post-MI induction period (dose was selected based on Kassan et al, 2009) on Day 1, 24 h after induction of MI; and (5) PRAV + BM-MNC group, in which rats were to be given both the IV injection of BM-MNC and daily oral PRAV as described above. As this study was meant to evaluate the effects of the drug ± BM-MNC on MIrelated outcomes, there were no formal control groups assessed that solely measured effects of PRAV, BM-MNC or the two regimens in combination on the endpoints outlined below.…”